Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pharmacy | 1 | 2024 | 9 | 0.220 |
Why?
|
| Pharmacies | 1 | 2024 | 11 | 0.220 |
Why?
|
| Graft vs Host Disease | 3 | 2010 | 366 | 0.190 |
Why?
|
| Crowding | 1 | 2019 | 6 | 0.160 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 36 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2024 | 555 | 0.160 |
Why?
|
| Triage | 1 | 2019 | 125 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2018 | 66 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2018 | 196 | 0.130 |
Why?
|
| Sinusitis | 1 | 2018 | 216 | 0.120 |
Why?
|
| Telemedicine | 1 | 2018 | 213 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 808 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2008 | 924 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 177 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 43 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2008 | 87 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2008 | 85 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 283 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2007 | 68 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 89 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 334 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 559 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 460 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2007 | 367 | 0.060 |
Why?
|
| Acute Disease | 3 | 2010 | 855 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2024 | 338 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2019 | 9689 | 0.040 |
Why?
|
| Colorado | 1 | 2019 | 37 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 58 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 925 | 0.040 |
Why?
|
| Infant | 3 | 2010 | 3207 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2010 | 3805 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 2978 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 390 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 790 | 0.030 |
Why?
|
| Transplantation, Homologous | 2 | 2008 | 1015 | 0.030 |
Why?
|
| Adult | 5 | 2024 | 27538 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1094 | 0.030 |
Why?
|
| Down Syndrome | 1 | 1995 | 54 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1774 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1903 | 0.030 |
Why?
|
| Adolescent | 4 | 2010 | 9495 | 0.030 |
Why?
|
| Humans | 7 | 2024 | 92339 | 0.030 |
Why?
|
| Child | 3 | 2010 | 7309 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 617 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2729 | 0.020 |
Why?
|
| Mass Screening | 1 | 1995 | 675 | 0.020 |
Why?
|
| Etanercept | 1 | 2007 | 33 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2007 | 138 | 0.020 |
Why?
|
| Aged | 3 | 2010 | 19951 | 0.020 |
Why?
|
| Female | 4 | 2018 | 47893 | 0.020 |
Why?
|
| Lymphoma | 1 | 2007 | 268 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 1179 | 0.020 |
Why?
|
| Male | 3 | 2018 | 43927 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 806 | 0.020 |
Why?
|
| Leukemia | 1 | 2007 | 324 | 0.010 |
Why?
|
| Middle Aged | 3 | 2010 | 27043 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 1926 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1761 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 843 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 2502 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2007 | 1150 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 3872 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1847 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 4471 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 6630 | 0.010 |
Why?
|
| Amniocentesis | 1 | 1995 | 31 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 8730 | 0.010 |
Why?
|
| United Kingdom | 1 | 1995 | 173 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 1995 | 110 | 0.010 |
Why?
|
| Counseling | 1 | 1995 | 171 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 2506 | 0.000 |
Why?
|
| Pregnancy | 1 | 1995 | 3112 | 0.000 |
Why?
|
| Risk Factors | 1 | 1995 | 5706 | 0.000 |
Why?
|